diaziquone has been researched along with Colorectal Cancer in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Ju, Y; Liu, R; Lu, Y; Niu, T; Qi, W; Wang, D; Yang, J; Zheng, L | 1 |
Ames, MM; Hartmann, LC; Reid, JM; Richardson, RL | 1 |
1 trial(s) available for diaziquone and Colorectal Cancer
Article | Year |
---|---|
Phase I trial of diaziquone (AZQ) plus GM-CSF.
Topics: Antineoplastic Agents; Aziridines; Benzoquinones; Blood Platelets; Bone Marrow; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drugs, Investigational; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Infusions, Intravenous; Injections, Subcutaneous; Melanoma; Neutrophils | 1995 |
1 other study(ies) available for diaziquone and Colorectal Cancer
Article | Year |
---|---|
CT-based radiomics for the identification of colorectal cancer liver metastases sensitive to first-line irinotecan-based chemotherapy.
Topics: Colorectal Neoplasms; Humans; Irinotecan; Liver Neoplasms; Retrospective Studies; Tomography, X-Ray Computed | 2023 |